Nistor Mirela, Nicolescu Alina, Amarandi Roxana-Maria, Pui Aurel, Stiufiuc Rares-Ionut, Dragoi Brindusa
Nanotechnology Laboratory, TRANSCEND Department, Regional Institute of Oncology, 2-4 General Henri Mathias Berthelot, Iasi, 700483, Romania.
Faculty of Chemistry, "Alexandru Ioan Cuza" University of Iasi, 11 Carol I Blvd., Iasi, 700506, Romania.
Sci Rep. 2025 Feb 12;15(1):5175. doi: 10.1038/s41598-025-89540-w.
Lipid-based drug delivery systems are very promising in addressing critical medical needs associated with cancer because they are able to enhance the efficacy of the therapeutic agents loaded in. Yet, their transferability from bench to bedside is still a challenge as it hits many barriers. Among them, the absence of a clear design made on the deeper understanding of the intermolecular forces underlying the formation of the drug-carrier system and the controlled release of the drug is relevant. In this contribution, we rationally designed and prepared lipid-based formulations of an anticancer drug, fluorouracil (FU - hydrophilic) and an anti-inflammatory drug, ibuprofen (IBU - hydrophobic) to thoroughly characterize the specific intermolecular interactions between drugs and components of the carrier matrix. Microemulsions (ME) were selected as the main carriers for this study, but a comparison with liposomes was performed to observe if different organization of the lipophilic and hydrophilic compartments influences the loading capacity and controlled release of these two drugs. Using Maisine CC, a biocompatible oil, and Tween 20 as the surfactant, normal oil-in-water ME loaded with FU and IBU (1:1, 1:3, 1:6, wt:wt) were prepared by the water titration method. MEs were characterized by DLS, Zeta potential, and DOSY spectroscopies to assess their droplet size, surface charge, structure and type of emulsion. Intermolecular interactions between drugs and components of the ME's matrix were investigated by FT-IR, RAMAN and H-NMR spectroscopies. The experimental results of DOSY revealed that all components of MEs are gathered in normal oil-in-water ME. Due to their different affinities for the main components of the ME, FU, and IBU were mainly distributed in the aqueous and oily phases, respectively, as supported by the droplet size measured by DLS. It was observed that co-loading the two drugs impacted the release behavior, assessed by the dialysis bag method, as compared with the mono-drug formulations. Based on the findings of this work, a release mechanism for FU and IBU was proposed, as well. Overall, the ME proved to be more suitable nanocarriers since the drugs, which were loaded in higher amounts as compared to liposomes, followed a controlled and sustained release of at least 96 h.
基于脂质的药物递送系统在满足与癌症相关的关键医疗需求方面非常有前景,因为它们能够提高所载治疗剂的疗效。然而,其从实验室到临床的可转化性仍然是一个挑战,因为它面临许多障碍。其中,由于缺乏基于对药物 - 载体系统形成和药物控释背后分子间力的深入理解而进行的清晰设计是相关的。在本论文中,我们合理设计并制备了抗癌药物氟尿嘧啶(FU - 亲水性)和抗炎药物布洛芬(IBU - 疏水性)的脂质基制剂,以全面表征药物与载体基质成分之间的特定分子间相互作用。微乳剂(ME)被选为本研究的主要载体,但与脂质体进行了比较,以观察亲脂性和亲水性隔室的不同组织方式是否会影响这两种药物的负载能力和控释。使用生物相容性油Maisine CC和吐温20作为表面活性剂,通过水滴定法制备了负载FU和IBU(1:1、1:3、1:6,重量比)的普通水包油型微乳剂。通过动态光散射(DLS)、zeta电位和扩散排序光谱(DOSY)对微乳剂进行表征,以评估其液滴大小、表面电荷、结构和乳液类型。通过傅里叶变换红外光谱(FT - IR)、拉曼光谱和氢核磁共振光谱(H - NMR)研究了药物与微乳剂基质成分之间的分子间相互作用。DOSY的实验结果表明,微乳剂的所有成分都聚集在普通水包油型微乳剂中。由于它们对微乳剂主要成分的亲和力不同,FU和IBU分别主要分布在水相和油相中,这得到了DLS测量的液滴大小的支持。观察到与单药制剂相比,同时负载这两种药物会影响通过透析袋法评估的释放行为。基于这项工作的发现,还提出了FU和IBU的释放机制。总体而言,微乳剂被证明是更合适的纳米载体,因为与脂质体相比,负载量更高的药物遵循至少96小时的控释和缓释。